デフォルト表紙
市場調査レポート
商品コード
1624308

在宅分子検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）

At-Home Molecular Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031

出版日
ページ情報
英文 221 Pages
納期
2～5営業日
在宅分子検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）
出版日: 2024年12月26日
発行: Fairfield Market Research
ページ情報: 英文 221 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

世界の在宅分子検査の市場規模は、2024年の115億5,000万米ドルから2031年末には170億9,000万米ドルに成長すると予測され、5.8％の堅調なCAGRが見込まれています。この急拡大する分野は、個人が自宅に居ながらにして便利に利用できる分子診断ソリューションの提供に重点を置いています。DNAやRNAのような遺伝物質を分析することにより、これらの検査は健康状態、遺伝的素因、家族の絆に関する洞察を提供します。

自宅での分子検査は、利用しやすい診断ソリューションを通じて積極的な健康管理を可能にすることで、ヘルスケアの状況を一変させつつあります。この市場は、分子生物学の進歩と個別化医療の魅力の高まりから恩恵を受け、遺伝子検査サービスに対する需要の急増を促しています。継続的な技術進歩により、これらの検査はより手頃な価格でユーザーフレンドリーになっており、多様な層で広く採用されるようになっています。

個別化医療は現代ヘルスケアの最前線にあり、個人の遺伝子プロファイルに合わせて医療介入を行います。遺伝的素因を理解することの利点に対する意識の高まりは、消費者が積極的な健康管理のために個別化された知見を求めるにつれて、在宅分子検査の需要を促進しています。

消費者は健康に対する積極的なアプローチをますます採用するようになっており、十分な情報に基づいたライフスタイルやヘルスケアの決定を行う力を与えてくれる、利用しやすい診断ツールを求めています。自宅で簡便に検査ができることは、このようなヘルスケア嗜好の変化と一致しています。

当レポートでは、世界の在宅分子検査市場について調査し、市場の概要とともに、製品別、サンプルタイプ別、検査タイプ別、流通チャネル別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の在宅分子検査市場の見通し、2019年～2031年

  • 世界の在宅分子検査市場の見通し、製品別、金額（10億米ドル）、数量（キロトン）、2019年～2031年
  • 世界の在宅分子検査市場の見通し、サンプルタイプ別、金額（10億米ドル）、数量（キロトン）、2019年～2031年
  • 世界の在宅分子検査市場の見通し、検査タイプ別、金額（10億米ドル）、数量（キロトン）、2019年～2031年
  • 世界の在宅分子検査市場の見通し、流通チャネル別、金額（10億米ドル）、数量（キロトン）、2019年～2031年
  • 世界の在宅分子検査市場の見通し、地域別、金額（10億米ドル）、数量（キロトン）、2019年～2031年

第4章 北米の在宅分子検査市場の見通し、2019年～2031年

第5章 欧州の在宅分子検査市場の見通し、2019年～2031年

第6章 アジア太平洋の在宅分子検査市場の見通し、2019年～2031年

第7章 ラテンアメリカの在宅分子検査市場の見通し、2019年～2031年

第8章 中東・アフリカの在宅分子検査市場の見通し、2019年～2031年

第9章 競合情勢

  • 検査タイプ別とサンプルタイプ別のヒートマップ
  • メーカー別サンプルタイプ別ヒートマップ
  • 企業市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG & Co. KGaA

第10章 付録

目次

The global at-home molecular testing market is forecast to grow from $11.55 billion in 2024 to $17.09 billion by the end of 2031, reflecting a robust compound annual growth rate (CAGR) of 5.8%. This rapidly expanding sector focuses on providing molecular diagnostic solutions that individuals can conveniently use from the comfort of their homes. By analyzing genetic material such as DNA or RNA, these tests offer insights into health conditions, genetic predispositions, and familial ties.

At-home molecular testing is transforming the healthcare landscape by enabling proactive health management through accessible diagnostic solutions. The market benefits from advancements in molecular biology and the growing appeal of personalized medicine, which has encouraged a surge in demand for genetic testing services. With continuous technological progress, these tests are becoming more affordable and user-friendly, driving widespread adoption across diverse demographics.

Market Growth Drivers

1.The Personalized Medicine Boom

  • Personalized medicine is at the forefront of modern healthcare, tailoring medical interventions to an individual's genetic profile.
  • The rising awareness of the benefits of understanding genetic predispositions is fueling the demand for at-home molecular testing, as consumers seek personalized insights for proactive health management.

2.Consumer-Driven Proactive Health Management

  • Consumers are increasingly adopting a proactive approach to health, seeking accessible diagnostic tools that empower them to make informed lifestyle and healthcare decisions.
  • The ability to conduct tests conveniently at home aligns with this shift in healthcare preferences.

3.Advancements in Molecular Biology

  • Technological advancements have simplified molecular testing processes, enabling easier sample collection and submission.
  • These innovations are broadening the market appeal and accessibility of at-home testing solutions.

Market Restraints

1.Challenges in Ensuring Precision and Reliability

  • Ensuring the accuracy of test results outside a clinical environment remains a challenge.
  • The absence of professional oversight during sample collection raises concerns about potential inaccuracies.

2.Regulatory Hurdles

  • The lack of uniform regulatory frameworks for at-home molecular testing creates challenges for manufacturers.
  • Striking a balance between fostering innovation and ensuring consumer safety is a critical concern for regulatory bodies.

Opportunities

1.Integration of AI and Machine Learning

  • The adoption of Artificial Intelligence (AI) and Machine Learning (ML) in genetic data analysis offers transformative potential.
  • These technologies can identify patterns and correlations in genetic data, enabling more precise and personalized health insights.

2.Expanding Consumer Reach Through Digital Platforms

  • The growing prevalence of e-commerce and online pharmacies enhances accessibility to at-home molecular testing kits.
  • Companies can leverage digital marketing and distribution channels to tap into a global consumer base.

Regional Analysis

1.North America: The Leading Region

  • North America is set to dominate the global at-home molecular testing market, driven by its advanced healthcare infrastructure and consumer awareness of personalized healthcare solutions.
  • The region's strong regulatory framework, coupled with the presence of major industry players, supports market growth.

2.Asia Pacific: A Rapidly Growing Market

  • Asia Pacific is expected to witness the fastest growth, driven by increasing incidences of chronic and infectious diseases in densely populated countries like China and India.
  • Rising disposable incomes, e-commerce growth, and demand for accessible healthcare solutions contribute to the region's market expansion.

Competitive Intelligence and Business Strategy

The at-home molecular testing market is highly competitive, with key players focusing on innovation, product differentiation, and strategic partnerships to strengthen their market positions.

Key Players Profiled

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • 23andMe
  • MyHeritage
  • AncestryDNA

At-Home Molecular Testing Market Segmentation

1.By Product

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others

2.By Test Type

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

3.By Sample Type

  • Urine
  • Blood
  • Saliva
  • Others

4.By Distribution Channel

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

5.By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-Home Molecular Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 3.1. Global At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Cassettes
      • 3.1.1.2. Test Panels
      • 3.1.1.3. Dip Cards
      • 3.1.1.4. Midstream
      • 3.1.1.5. Strips
      • 3.1.1.6. Others
  • 3.2. Global At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Urine
      • 3.2.1.2. Blood
      • 3.2.1.3. Saliva
      • 3.2.1.4. Others
  • 3.3. Global At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Pregnancy Tests
      • 3.3.1.2. HIV Tests
      • 3.3.1.3. Diabetes
      • 3.3.1.4. Infectious Diseases
      • 3.3.1.5. Glucose Tests
      • 3.3.1.6. Ovulation Predictor Tests
      • 3.3.1.7. Drug Abuse Tests
      • 3.3.1.8. Others
  • 3.4. Global At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Retail Pharmacies
      • 3.4.1.2. Drug Stores
      • 3.4.1.3. Supermarkets/Hypermarkets
      • 3.4.1.4. Online Pharmacies
  • 3.5. Global At-Home Molecular Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 4.1. North America At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Cassettes
      • 4.1.1.2. Test Panels
      • 4.1.1.3. Dip Cards
      • 4.1.1.4. Midstream
      • 4.1.1.5. Strips
      • 4.1.1.6. Others
  • 4.2. North America At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Urine
      • 4.2.1.2. Blood
      • 4.2.1.3. Saliva
      • 4.2.1.4. Others
  • 4.3. North America At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Pregnancy Tests
      • 4.3.1.2. HIV Tests
      • 4.3.1.3. Diabetes
      • 4.3.1.4. Infectious Diseases
      • 4.3.1.5. Glucose Tests
      • 4.3.1.6. Ovulation Predictor Tests
      • 4.3.1.7. Drug Abuse Tests
      • 4.3.1.8. Others
  • 4.4. North America At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Retail Pharmacies
      • 4.4.1.2. Drug Stores
      • 4.4.1.3. Supermarkets/Hypermarkets
      • 4.4.1.4. Online Pharmacies
  • 4.5. North America At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.2. U.S. At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.3. U.S. At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.4. U.S. At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.5. Canada At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.6. Canada At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.7. Canada At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 4.5.1.8. Canada At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 5.1. Europe At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Cassettes
      • 5.1.1.2. Test Panels
      • 5.1.1.3. Dip Cards
      • 5.1.1.4. Midstream
      • 5.1.1.5. Strips
      • 5.1.1.6. Others
  • 5.2. Europe At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Urine
      • 5.2.1.2. Blood
      • 5.2.1.3. Saliva
      • 5.2.1.4. Others
  • 5.3. Europe At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Pregnancy Tests
      • 5.3.1.2. HIV Tests
      • 5.3.1.3. Diabetes
      • 5.3.1.4. Infectious Diseases
      • 5.3.1.5. Glucose Tests
      • 5.3.1.6. Ovulation Predictor Tests
      • 5.3.1.7. Drug Abuse Tests
      • 5.3.1.8. Others
  • 5.4. Europe At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Retail Pharmacies
      • 5.4.1.2. Drug Stores
      • 5.4.1.3. Supermarkets/Hypermarkets
      • 5.4.1.4. Online Pharmacies
  • 5.5. Europe At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.2. Germany At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.3. Germany At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.4. Germany At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.5. U.K. At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.6. U.K. At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.7. U.K. At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.8. U.K. At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.9. France At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.10. France At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.11. France At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.12. France At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.13. Italy At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.14. Italy At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.15. Italy At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.16. Italy At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.17. Turkey At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.18. Turkey At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.19. Turkey At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.20. Turkey At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.21. Russia At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.22. Russia At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.23. Russia At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.24. Russia At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.25. Rest of Europe At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.26. Rest of Europe At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.27. Rest of Europe At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 5.5.1.28. Rest of Europe At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Cassettes
      • 6.1.1.2. Test Panels
      • 6.1.1.3. Dip Cards
      • 6.1.1.4. Midstream
      • 6.1.1.5. Strips
      • 6.1.1.6. Others
  • 6.2. Asia Pacific At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Urine
      • 6.2.1.2. Blood
      • 6.2.1.3. Saliva
      • 6.2.1.4. Others
  • 6.3. Asia Pacific At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Pregnancy Tests
      • 6.3.1.2. HIV Tests
      • 6.3.1.3. Diabetes
      • 6.3.1.4. Infectious Diseases
      • 6.3.1.5. Glucose Tests
      • 6.3.1.6. Ovulation Predictor Tests
      • 6.3.1.7. Drug Abuse Tests
      • 6.3.1.8. Others
  • 6.4. Asia Pacific At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Retail Pharmacies
      • 6.4.1.2. Drug Stores
      • 6.4.1.3. Supermarkets/Hypermarkets
      • 6.4.1.4. Online Pharmacies
  • 6.5. Asia Pacific At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.2. China At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.3. China At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.4. China At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.5. Japan At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.6. Japan At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.7. Japan At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.8. Japan At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.9. South Korea At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.10. South Korea At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.11. South Korea At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.12. South Korea At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.13. India At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.14. India At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.15. India At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.16. India At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.17. Southeast Asia At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.18. Southeast Asia At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.19. Southeast Asia At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.20. Southeast Asia At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.21. Rest of Asia Pacific At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.22. Rest of Asia Pacific At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.23. Rest of Asia Pacific At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 6.5.1.24. Rest of Asia Pacific At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 7.1. Latin America At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Cassettes
      • 7.1.1.2. Test Panels
      • 7.1.1.3. Dip Cards
      • 7.1.1.4. Midstream
      • 7.1.1.5. Strips
      • 7.1.1.6. Others
  • 7.2. Latin America At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.2.1.1. Urine
      • 7.2.1.2. Blood
      • 7.2.1.3. Saliva
      • 7.2.1.4. Others
  • 7.3. Latin America At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Pregnancy Tests
      • 7.3.1.2. HIV Tests
      • 7.3.1.3. Diabetes
      • 7.3.1.4. Infectious Diseases
      • 7.3.1.5. Glucose Tests
      • 7.3.1.6. Ovulation Predictor Tests
      • 7.3.1.7. Drug Abuse Tests
      • 7.3.1.8. Others
  • 7.4. Latin America At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Retail Pharmacies
      • 7.4.1.2. Drug Stores
      • 7.4.1.3. Supermarkets/Hypermarkets
      • 7.4.1.4. Online Pharmacies
  • 7.5. Latin America At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.2. Brazil At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.3. Brazil At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.4. Brazil At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.5. Mexico At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.6. Mexico At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.7. Mexico At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.8. Mexico At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.9. Argentina At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.10. Argentina At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.11. Argentina At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.12. Argentina At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.13. Rest of Latin America At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.14. Rest of Latin America At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.15. Rest of Latin America At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 7.5.1.16. Rest of Latin America At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa At-Home Molecular Testing Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa At-Home Molecular Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Cassettes
      • 8.1.1.2. Test Panels
      • 8.1.1.3. Dip Cards
      • 8.1.1.4. Midstream
      • 8.1.1.5. Strips
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa At-Home Molecular Testing Market Outlook, by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Urine
      • 8.2.1.2. Blood
      • 8.2.1.3. Saliva
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa At-Home Molecular Testing Market Outlook, by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Pregnancy Tests
      • 8.3.1.2. HIV Tests
      • 8.3.1.3. Diabetes
      • 8.3.1.4. Infectious Diseases
      • 8.3.1.5. Glucose Tests
      • 8.3.1.6. Ovulation Predictor Tests
      • 8.3.1.7. Drug Abuse Tests
      • 8.3.1.8. Others
  • 8.4. Middle East & Africa At-Home Molecular Testing Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Retail Pharmacies
      • 8.4.1.2. Drug Stores
      • 8.4.1.3. Supermarkets/Hypermarkets
      • 8.4.1.4. Online Pharmacies
  • 8.5. Middle East & Africa At-Home Molecular Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.2. GCC At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.3. GCC At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.4. GCC At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.5. South Africa At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.6. South Africa At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.7. South Africa At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.8. South Africa At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.9. Egypt At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.10. Egypt At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.11. Egypt At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.12. Egypt At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.13. Nigeria At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.14. Nigeria At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.15. Nigeria At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.16. Nigeria At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.17. Rest of Middle East & Africa At-Home Molecular Testing Market by Product, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.18. Rest of Middle East & Africa At-Home Molecular Testing Market by Sample Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.19. Rest of Middle East & Africa At-Home Molecular Testing Market by Test Type, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
      • 8.5.1.20. Rest of Middle East & Africa At-Home Molecular Testing Market by Distribution Channel, Value (US$ Bn) and Volume (Kilo Ton), 2019 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Test Type vs by Sample Type Heat map
  • 9.2. Manufacturer vs by Sample Type Heat map
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Abbott
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. ACON Laboratories, Inc.
    • 9.5.3. Rapikit
    • 9.5.4. Becton and Dickinson
    • 9.5.5. Cardinal Health
    • 9.5.6. B. Braun Melsungen AG
    • 9.5.7. Piramal Enterprises Ltd.
    • 9.5.8. Siemens Healthcare GmbH
    • 9.5.9. Quidel Corporation
    • 9.5.10. Bionime Corporation
    • 9.5.11. SA Scientific
    • 9.5.12. ARKRAY USA, Inc.
    • 9.5.13. Nova Biomedical
    • 9.5.14. AdvaCare Pharma
    • 9.5.15. AccuBioTech Co., Ltd.
    • 9.5.16. Atlas Medical UK
    • 9.5.17. TaiDoc Technology Corporation
    • 9.5.18. Dragerwerk AG & Co. KGaA

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations